A.J. Grillo-López

The University of Texas MD Anderson Cancer Center — United States

Medicine · Health Sciences

27h-index8.9kcitations64works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(46), Monoclonal and Polyclonal Antibodies Research(20), Chronic Lymphocytic Leukemia Research(18), CAR-T cell therapy research(16), Radiopharmaceutical Chemistry and Applications(12)

Publications64 total

Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program
Journal of Clinical Oncology·2023· 120 cited
Prognostic factors for non-Hodgkin's lymphoma patients treated with chemotherapy may not predict outcome in patients treated with rituximab
Leukemia & lymphoma/Leukemia and lymphoma·2006· 26 cited
Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma
Leukemia & lymphoma/Leukemia and lymphoma·2005· 48 cited
Rituximab in Combination With Fludarabine Chemotherapy in Low-Grade or Follicular Lymphoma
Journal of Clinical Oncology·2005· 144 citedOpen Access
Treatment of relapsed B-cell non-Hodgkin's lymphoma with a combination of chimeric anti-CD20 monoclonal antibodies (rituximab) and G-CSF: final report on safety and efficacy
Leukemia·2003· 63 cited
Complement activation plays a key role in the side‐effects of rituximab treatment
British Journal of Haematology·2001· 322 citedOpen Access
Non-Hodgkins Lymphoma: Review of Conventional Treatments
Current Pharmaceutical Biotechnology·2001· 32 cited
Monoclonal Antibodies: A New Era in the Treatment of Non-Hodgkins Lymphoma
Current Pharmaceutical Biotechnology·2001· 20 cited
Ibritumomab Tiuxetan Radioimmunotherapy Improves Quality of Life in Patients With Low-Grade, Follicular, or Transformed Non-Hodgkin’s Lymphoma
2001
Rituximab: Sustained Remissions in Patients With Relapsed or Refractory Low-Grade or Follicular Non-Hodgkin’s Lymphoma
2001· 4 cited
Ibritumomab Tiuxetan Radioimmunotherapy Is Safe and Well Tolerated in Patients With Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma
2001
A Pilot Study of Anti-CD20 Monoclonal Antibody Rituximab in Patients With Refractory Immune Thrombocytopenic Purpura
2001· 1 cited
Ibritumomab Tiuxetan Radioimmunotherapy of Rituximab-Refractory Follicular Non-Hodgkin’s Lymphoma
2001
Peripheral Blood B-Cell Recovery in Patients With Non-Hodgkin’s Lymphoma Treated With Rituximab Does Not Correlate With Onset of Disease Progression
2001· 2 cited
Final Results of a Randomized Controlled Study of the Ibritumomab Tiuxetan Radioimmunotherapy Regimen vs a Standard Course of Rituximab Immunotherapy for B-Cell Non-Hodgkin’s Lymphoma
2001
Phase II Study of Rituximab in Combination With CHOP Chemotherapy in Patients With Previously Untreated, Aggressive Non-Hodgkin’s Lymphoma
Journal of Clinical Oncology·2001· 416 cited
Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy
Annals of Oncology·2001· 67 citedOpen Access
Phase I I S tudy o f R ituximab i n C ombination W ith C HOP Chemotherapy i n P atients W ith P reviously U ntreated, Aggressive N on-Hodgkin's L ymphoma
2001
Multicenter experience with the zevalin radiolabeling kit for radioimmunotherapy of non-hodgkin's lymphoma
2000· 1 cited
Baseline peripheral blood B-cell levels correlate with disease-free interval and response to zevalin radioimmunotherapy of relapsed non-hodgkin's lymphoma
2000
page 1 of 4Next →

Frequent Co-authors

Christine A. White(17), M. S. Czuczman(12), C. Varns(10), Ronald Levy(9), B.K. Dallaire(8), Leo I. Gordon(8), J. Rosenberg(8), Peter McLaughlin(7), Brian K. Link(6), DG Maloney(6), Diying Shen(5), Gregory A. Wiseman(5), Thomas E. Witzig(5), C.A. White(4), Pratik S. Multani(4), Fernando Cabanillas(3), Donald Klippenstein(3), TM Liles(3), David G. Maloney(3), Nalini Janakiraman(3)